In her role, Bumpus will serve as a part-time strategic advisor to Charles River, a spokesperson for the company told Fierce ...

While the benefits of AI are clear, the amount data sets needed for effective AI integration is proving to be a challenge.

Charles River announces Scientific Advisory Board, led by Dr. Namandjé N. Bumpus, to support industry adoption of NAMs.

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the creation of a global, cross-functional Scientific Advisory Board, led by Dr. Namandjé N. Bumpus, to guide the Company’s ...

PRINCETON, N.J.--(BUSINESS WIRE)--NJ Bio, Inc. and Charles River Laboratories, Inc. have announced a strategic alliance to offer complementary services to clients including early development and ...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

Charles River &Toxys announce collaboration to validate use of ReproTracker®, an in vitro alternative for developmental & reproductive toxicology.

Conduit Pharmaceuticals partners with Charles River to evaluate AZD1656 for lupus, enhancing preclinical research and improving Phase II trial success. Conduit Pharmaceuticals has announced a ...

Charles River Laboratories International, Inc. (NYSE: CRL) has joined the EASYGEN (Easy Workflow Integration for Gene Therapy) Consortium, a European Union (EU)-backed effort to produce CAR-T cell ...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL), ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has ...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Elly’s Team, a parent-led foundation striving to find a cure for Neurodevelopmental Disorder with ...

Artificial wetlands like the one in the Charles River can remove phosphorus from polluted urban waterways, create new ...